[go: up one dir, main page]

AR003496A1 - Procedimiento de tratamiento cosmetico no terapeutico de desordenes asociados con un exceso de sintesis y/o liberacion del cgrp y/o de sustancia p utilizacion de al menos un extracto de celulas de la menos un vegetal de la familia de las iridaceas y composicion cosmetica o farmaceutica que comprende dicho extracto - Google Patents

Procedimiento de tratamiento cosmetico no terapeutico de desordenes asociados con un exceso de sintesis y/o liberacion del cgrp y/o de sustancia p utilizacion de al menos un extracto de celulas de la menos un vegetal de la familia de las iridaceas y composicion cosmetica o farmaceutica que comprende dicho extracto

Info

Publication number
AR003496A1
AR003496A1 ARP960104218A AR10421896A AR003496A1 AR 003496 A1 AR003496 A1 AR 003496A1 AR P960104218 A ARP960104218 A AR P960104218A AR 10421896 A AR10421896 A AR 10421896A AR 003496 A1 AR003496 A1 AR 003496A1
Authority
AR
Argentina
Prior art keywords
family
cgrp
iridacean
release
cell
Prior art date
Application number
ARP960104218A
Other languages
English (en)
Original Assignee
Oréal L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9510486A external-priority patent/FR2738486B1/fr
Priority claimed from FR9510487A external-priority patent/FR2738488B1/fr
Priority claimed from FR9603815A external-priority patent/FR2746647B1/fr
Application filed by Oréal L filed Critical Oréal L
Publication of AR003496A1 publication Critical patent/AR003496A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)

Abstract

La presente invención tiene por objeto en su aspecto más general un extracto de células de al menos un vegetal de la familia de las iridáceas,siendo el mencionado vegetal obtenido por cultivo in vitro. La invención tiene igualmente porobjet o las composiciones que contienen un extracto de células deal menos un vegetal de la familia de las iridáceas, la utilización dichos extractos como antagonista del CGRP y/o de la sustancia P y un procedimiento detratamiento cosmético queutiliz a una de dichas composiciones.
ARP960104218A 1995-09-07 1996-09-04 Procedimiento de tratamiento cosmetico no terapeutico de desordenes asociados con un exceso de sintesis y/o liberacion del cgrp y/o de sustancia p utilizacion de al menos un extracto de celulas de la menos un vegetal de la familia de las iridaceas y composicion cosmetica o farmaceutica que comprende dicho extracto AR003496A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9510486A FR2738486B1 (fr) 1995-09-07 1995-09-07 Utilisation d'au moins un extrait d'au moins une iridacee dans une composition cosmetique ou pharmaceutique
FR9510487A FR2738488B1 (fr) 1995-09-07 1995-09-07 Composition contenant a titre de principe actif au moins un extrait d'au moins une iridacee
FR9603815A FR2746647B1 (fr) 1996-03-27 1996-03-27 Composition apaisante comprenant un extrait d'iridacee

Publications (1)

Publication Number Publication Date
AR003496A1 true AR003496A1 (es) 1998-08-05

Family

ID=27253096

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960104218A AR003496A1 (es) 1995-09-07 1996-09-04 Procedimiento de tratamiento cosmetico no terapeutico de desordenes asociados con un exceso de sintesis y/o liberacion del cgrp y/o de sustancia p utilizacion de al menos un extracto de celulas de la menos un vegetal de la familia de las iridaceas y composicion cosmetica o farmaceutica que comprende dicho extracto

Country Status (12)

Country Link
US (1) US6471997B1 (es)
EP (1) EP0765668B1 (es)
JP (1) JP3093154B2 (es)
AR (1) AR003496A1 (es)
BR (1) BR9610375A (es)
CA (1) CA2185037C (es)
DE (1) DE69601765T2 (es)
ES (1) ES2132855T3 (es)
MX (1) MX9710479A (es)
PL (1) PL186769B1 (es)
RU (1) RU2169000C2 (es)
WO (1) WO1997009056A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2746641B1 (fr) * 1996-03-27 1998-06-05 Oreal Utilisation d'un extrait d'au moins une iridacee dans le traitement des rides
FR2768621B1 (fr) * 1997-09-22 2000-04-07 Oreal Utilisation d'un extrait d'au moins un vegetal de la famille des rosacees
DE19812204A1 (de) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
US20050037100A1 (en) * 1998-03-19 2005-02-17 Bionorica Ag Utilization of extracts from iris plants, cimicifuga racemose and tectorigenin as an estrogen-like organ-selective medicament without uterotropic
JPH11269066A (ja) * 1998-03-20 1999-10-05 Kao Corp 経口用美白剤及び美白用食品
DE19918750A1 (de) * 1999-04-24 2000-10-26 Beiersdorf Ag Wirkstoffe, kosmetische und dermatologische Zubereitungen für die Verbesserung der Barrierefunktion
FR2795637A1 (fr) * 1999-07-02 2001-01-05 Oreal Utilisation de cellules vegetales dedifferenciees
DE19937304C2 (de) * 1999-08-10 2003-08-21 Boehringer Ingelheim Pharma Verwendung von CGRP-Antagonisten zur Bekämpfung menopausaler Hitzewallungen
IL151334A0 (en) * 2000-02-28 2003-04-10 Natural Remedies Private Ltd An improved herbal composition having antiallergic properties and a process for the preparation thereof
FR2811893B1 (fr) * 2000-07-18 2003-04-18 Oreal Utilisation d'au moins un extrait d'au moins une iridacee dans une composition destinee a stimuler defenses immunitaires
JP4698810B2 (ja) * 2000-10-13 2011-06-08 日本メナード化粧品株式会社 皮膚外用剤
DE10111050A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigenOrganismus ihre Wirkung entfaltet, zur Herstellung von kosmetischewn oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe unerwünschter Hautpigmentierung
DE10111049A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen, zur Prophylaxe und Behandlung von entzündlichen Hautzuständen und/oder zum Hautschutz bei empfindlich determinierter trockener Haut
DE10111052A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthase des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Steigerung der Ceramidbiosynthese
DE10111054A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Substanzen, die verhindern, daß die NO-Synthese des warmblütigen Organismus ihre Wirkung entfaltet, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Stärkung der Barrierefunktion der Haut
DE10146159A1 (de) 2001-09-19 2003-04-10 Bionorica Ag Verwendung von Extrakten aus Cimicifuga-Arten als organselektives Arzneimittel zur Behandlung von sexualhormonabhängigen Erkrankungen des Urogenitaltraktes
RU2201255C1 (ru) * 2001-12-26 2003-03-27 Эпштейн Олег Ильич Лекарственное средство и способ регуляции сосудистого тонуса
DE10206390A1 (de) * 2002-02-15 2003-08-28 Bionorica Ag Verwendung von selektiv den Estrogenrezeptor beta modulierenden phytoestrogenhaltigen Extrakten
RU2244538C2 (ru) * 2002-03-19 2005-01-20 Дворяшин Сергей Николаевич Способ лечения рубцов кожи
BRPI0411098A (pt) * 2003-06-05 2006-07-18 Warner Lambert Co benzofuranocarboxamidas, com atividade pi3k, como agentes terapêuticos
US20040259926A1 (en) * 2003-06-05 2004-12-23 Bruendl Michelle M. 3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
CA2527779A1 (en) * 2003-06-05 2004-12-16 Warner-Lambert Company Llc 3-substituted indoles and derivatives thereof as therapeutic agents
BRPI0411092A (pt) * 2003-06-05 2006-07-18 Warner Lambert Co benzo[b]tiofenos substituìdos com 3-arilsulfanila e com 3-heteroarilsulfanila como agentes terapêuticos
JP2006526606A (ja) * 2003-06-05 2006-11-24 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー 治療薬としてのシクロアルキル及びヘテロシクロアルキル置換されるベンゾチオフェン
MXPA05013210A (es) * 2003-06-05 2006-03-09 Warner Lambert Co Benzo[b]tiofenos cicloalquilsulfanil-sustituidos como agentes terapeuticos.
ITMI20032286A1 (it) * 2003-11-24 2005-05-25 Indena Spa Composizioni per il trattamento di dermatiti atopiche di stati allergici cutanei e dell'acne
RU2253461C1 (ru) * 2004-04-30 2005-06-10 Общество с ограниченной ответственностью "Паркинфарм" Фармацевтическая комбинация, оказывающая влияние на функционирование цнс, способ коррекции состояний, связанных с нарушениями функционирования цнс; фармацевтический набор; средство, способствующее проникновению через гематоэнцефалический барьер лекарственных субстанций и метаболитов; фармацевтическое средство для эндоназального применения
US7300649B2 (en) 2005-02-11 2007-11-27 Genepharm, Inc. Cosmetic and cosmeceutical compositions for restoration of skin barrier function
FR2916351B1 (fr) 2007-05-22 2012-12-07 Galderma Res & Dev Composition pharmaceutique comprenant au moins deux composes choisis parmi l'acide pyrrolidone-5-carboxylique, la citrulline, l'arginine et l'asparagine et leur utilisation dans le traitement de la dermatite atopique
WO2012007845A2 (en) 2010-07-15 2012-01-19 Oleg Iliich Epshtein A method of increasing the effect of an activated-potentiated form of an antibody
CN102869326B (zh) * 2010-06-09 2017-04-05 花王株式会社 水蒸气产生温热器
FR2970868B1 (fr) * 2011-01-31 2023-10-27 Sederma Sa Extrait d'origine vegetale, composition le contenant, procede d'obtention par culture vegetale et utilisations dans les domaines cosmetique, pharmaceutique et cosmeceutique
KR101967615B1 (ko) * 2011-02-01 2019-04-10 가부시기가이샤하야시바라 피부 외용제
JP5923375B2 (ja) 2012-04-24 2016-05-24 花王株式会社 Ｃｇｒｐ応答性促進剤
FR3001391B1 (fr) * 2013-01-29 2017-07-07 Oreal Utilisation de cellules vegetales d'iridacee elicitees dans le traitement des peaux sensibles
JP6317993B2 (ja) * 2014-05-07 2018-04-25 ポーラ化成工業株式会社 肌改善剤のスクリーニング方法
US20160367499A1 (en) 2014-11-18 2016-12-22 Universitaet Basel Promotion of lymphatic function
JPWO2019017355A1 (ja) * 2017-07-18 2020-05-28 株式会社 資生堂 間葉系幹細胞誘引剤
CN112956733B (zh) * 2021-02-07 2023-06-20 无锡华叶生物科技有限公司 一种烟用鸢尾根分离物的制备方法
EP4342448A4 (en) * 2021-08-18 2025-06-25 Exocobio Inc. Novel composition comprising iris-derived exosome as active ingredient
KR102348510B1 (ko) * 2021-08-27 2022-01-07 주식회사 에이바이오머티리얼즈 붓꽃 구근 유래 엑소좀을 유효성분으로 함유하는 화장료 조성물
CN114409544B (zh) * 2022-01-30 2023-06-13 西安交通大学 具有血管舒张活性的苯丙素及其提取方法和应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6261924A (ja) * 1985-09-11 1987-03-18 Shiseido Co Ltd 皮膚外用剤
JPS62289509A (ja) * 1986-06-10 1987-12-16 Shiseido Co Ltd 頭髪化粧料
JPS63196522A (ja) * 1987-02-10 1988-08-15 Zeria Shinyaku Kogyo Kk 抗消化性潰瘍剤
JPS63216824A (ja) * 1987-03-05 1988-09-09 Zeria Shinyaku Kogyo Kk 抗消化性潰瘍剤
US4963480A (en) * 1988-08-05 1990-10-16 Roure S.A. Process for the preparation of gamma-irone
JPH02142743A (ja) * 1988-11-22 1990-05-31 Zeria Pharmaceut Co Ltd テルペン化合物及び該化合物を含有する抗消化性潰瘍剤
JPH02163017A (ja) * 1988-12-13 1990-06-22 Shiseido Co Ltd イリス属植物の組織培養方法
JP3314785B2 (ja) * 1990-09-28 2002-08-12 大正製薬株式会社 ミノキシジル含有育毛剤
JPH04182446A (ja) * 1990-11-15 1992-06-30 Otsuka Pharmaceut Co Ltd ベンゼン誘導体
CH683594A5 (de) * 1991-01-24 1994-04-15 Flachsmann Ag Emil Verfahren zur Herstellung eines Pflanzenextrakt enthaltenden Masse, welche insbesondere für die Einkapselung in ein festes Umhüllungsmaterial geeignet ist.
JP2955055B2 (ja) * 1991-03-30 1999-10-04 鐘紡株式会社 養毛化粧料
JP3607709B2 (ja) * 1991-04-02 2005-01-05 大正製薬株式会社 皮膚外用保湿剤
RU2005468C1 (ru) * 1992-01-28 1994-01-15 Акционерное общество закрытого типа "ИНЭКОЛ" Питательный крем для кожи лица
JPH05221915A (ja) * 1992-02-14 1993-08-31 Mitsubishi Kasei Corp １，４−ベンゾキノン誘導体
JPH06327484A (ja) * 1993-05-21 1994-11-29 Shiseido Co Ltd イロン類の製造方法
JP3605420B2 (ja) * 1993-07-14 2004-12-22 三省製薬株式会社 皮膚外用剤
CA2171446C (en) * 1993-09-09 2004-11-23 Donald James Kyle Pseudo- and non-peptide bradykinin receptor antagonists
US5364881A (en) * 1993-11-15 1994-11-15 The Medical College Of Wisconsin Research Foundation, Inc. S-alkyl-isothioureido-amino acids and use thereof
JP3501832B2 (ja) * 1993-11-15 2004-03-02 一丸ファルコス株式会社 ヒオウギ抽出物を含有するテストステロン５α−リダクターゼ阻害剤とその応用
JP3294694B2 (ja) * 1993-11-15 2002-06-24 一丸ファルコス株式会社 ヒオウギ抽出物を含有する細胞賦活剤とその応用
JP3078694B2 (ja) * 1993-12-17 2000-08-21 キッコーマン株式会社 ゲニステインの製造法
JPH07285845A (ja) * 1994-04-19 1995-10-31 Pola Chem Ind Inc 皮膚化粧料
FR2719474B1 (fr) * 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.
US5550132A (en) * 1994-06-22 1996-08-27 University Of North Carolina Hydroxyalkylammonium-pyrimidines or purines and nucleoside derivatives, useful as inhibitors of inflammatory cytokines
JP3803398B2 (ja) * 1994-08-01 2006-08-02 ポーラ化成工業株式会社 人体過剰対応抑制剤
JP3769036B2 (ja) * 1994-08-01 2006-04-19 ポーラ化成工業株式会社 人体過剰対応抑制剤
JPH0859536A (ja) * 1994-08-12 1996-03-05 Shiseido Co Ltd 新規トリテルペノイド類
PL315636A1 (en) * 1994-11-25 1996-11-25 Rocher Yves Biolog Vegetale Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
US5716625A (en) 1994-12-21 1998-02-10 Cosmederm Technologies Formulations and methods for reducing skin irritation
JPH11502504A (ja) 1994-12-21 1999-03-02 コスメダーム・テクノロジーズ 皮膚刺激を軽減するための製剤および方法
JPH10511360A (ja) 1994-12-21 1998-11-04 コスメダーム・テクノロジーズ 皮膚刺激を軽減するための製剤および方法
FR2728793A1 (fr) * 1994-12-28 1996-07-05 Oreal Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
FR2729855A1 (fr) * 1995-01-26 1996-08-02 Oreal Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
JPH08301758A (ja) * 1995-04-28 1996-11-19 Shiseido Co Ltd 皮膚外用剤
JP3481386B2 (ja) * 1995-05-17 2003-12-22 株式会社資生堂 美白用皮膚外用剤
BR9608500A (pt) * 1995-09-07 1999-07-06 Oreal Utilização de pelo menos um extrato de pelo menos uma bactéria filamentosa não fotossintética composição cosmética ou farmacêutica e processo de tratamento cosméstico
FR2738741B1 (fr) * 1995-09-19 1997-12-05 Oreal Composition pour la teinture des fibres keratiniques, contenant un antagoniste de substance p
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
FR2768621B1 (fr) * 1997-09-22 2000-04-07 Oreal Utilisation d'un extrait d'au moins un vegetal de la famille des rosacees
FR2772610B1 (fr) * 1997-12-19 2006-06-02 Oreal Utilisation de l'acide cinnamique ou d'au moins l'un de ses derives dans une composition cosmetique
FR2777186B1 (fr) * 1998-04-10 2001-03-09 Oreal Utilisation d'au moins un hydroxystilbene dans une composition raffermissante

Also Published As

Publication number Publication date
ES2132855T3 (es) 1999-08-16
CA2185037C (fr) 2007-06-26
US6471997B1 (en) 2002-10-29
DE69601765T2 (de) 1999-07-08
RU2169000C2 (ru) 2001-06-20
DE69601765D1 (de) 1999-04-22
MX9710479A (es) 1998-03-31
JPH09124499A (ja) 1997-05-13
EP0765668A1 (fr) 1997-04-02
EP0765668B1 (fr) 1999-03-17
JP3093154B2 (ja) 2000-10-03
CA2185037A1 (fr) 1997-03-08
PL324558A1 (en) 1998-06-08
PL186769B1 (pl) 2004-02-27
WO1997009056A1 (fr) 1997-03-13
BR9610375A (pt) 1999-07-06

Similar Documents

Publication Publication Date Title
AR003496A1 (es) Procedimiento de tratamiento cosmetico no terapeutico de desordenes asociados con un exceso de sintesis y/o liberacion del cgrp y/o de sustancia p utilizacion de al menos un extracto de celulas de la menos un vegetal de la familia de las iridaceas y composicion cosmetica o farmaceutica que comprende dicho extracto
ES2182107T3 (es) Uso en una composicion de un extracto de al menos una labiada del genero rosmarinarus, cultivado in vitro.
DE60227068D1 (de) Therapeutische verfahren unter verwendung von pflanzlichen zusammensetzungen
PE799A1 (es) Composicion cosmetica que contiene un antagonista de los receptores del neuropeptido y
AR003989A1 (es) Composicion cosmetica o farmaceutica y procedimiento de tratamiento cosmetico, excluido tdo tratamiento terapeutico que utiliza la composicion cosmetica.
ES2056943T3 (es) Complejos de fosfolipidos y extractos de vitis vinifera, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticos que los contienen.
BR0315275A (pt) Anticorpos que se ligam a receptor de eritropoietina
MXPA01005545A (es) Composicion y metodo para tratamiento de cancer que usan moduladores de transduccion de senales y aceites esenciales vegetales naturales.
DE60132429D1 (de) Pluripotente stammzellen erzeugt aus stromalzellen aus dem fettgewebe und deren verwendungen
DE60125708D1 (de) Zusammensetzung zur topischen Anwendung
SV2001000004A (es) Difenil ureas w-carboxyaril sustituidas, composición farmacéutica que las comprende y su uso como inhibidores de raf quinasa
ES2174328T3 (es) Substancias con actividad biologica, su procedimiento de obtencion y las composiciones que las incluyen.
BR0108564A (pt) Preparações cosméticas contendo extratos vegetais
ES2009223A6 (es) Material antioxidante, procedimiento para prepararlo y composiciones cosmeticas y alimenticias que contienen dicho material.
ATE97316T1 (de) Kosmetisches mittel und zusammensetzung zur behandlung der haut.
ES2156107T3 (es) Un fgf-4 no glicosilado y composiciones que lo contienen.
DE60219782D1 (de) Pharmazeutische und/oder kosmetische zusammensetzung zur behandlung von lokaler adipositas und zellulitis
MXPA02004933A (es) Composiciones cosmeticas conteniendo extracto de garbanzo y retinoides.
BR0316003A (pt) Lenços e produtos absorventes contendo antioxidante
DK0563085T3 (da) Hidtil ukendte præparater
BR9910941A (pt) Extratos de hypericum perforatum e formulações contendo os mesmos
DK1390008T3 (da) Farmaceutiske og kosmetiske sammensætninger omfattende phospholipidkomplekser af ekstrakter af vitis vinifera og centella asiatica
BR0002822A (pt) Composição, utilização de pelo menos um extrato de pelo menos um vegetal do gênero saxifraga e processo de tratamento cosmético para colorir a pele
ES2055319T3 (es) Composiciones quimicas de base acuosa.
DK1517694T3 (da) Planteekstrakter

Legal Events

Date Code Title Description
FC Refusal